Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v6-EN
Language English English
Date Updated 2022-04-21 2022-04-21
Drug Identification Number 00061085 00061085
Brand name LACTATED RINGER'S INJECTION, USP LACTATED RINGER'S INJECTION, USP
Common or Proper name Lactated Ringer's Injection USP Lactated Ringer's Injection USP
Company Name BAXTER CORPORATION BAXTER CORPORATION
Ingredients CALCIUM CHLORIDE POTASSIUM CHLORIDE SODIUM LACTATE SODIUM CHLORIDE CALCIUM CHLORIDE POTASSIUM CHLORIDE SODIUM LACTATE SODIUM CHLORIDE
Strength(s) 20MG 30MG 310MG 600MG 20MG 30MG 310MG 600MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 1000ML 1000ML
ATC code B05BB B05BB
ATC description I.V. SOLUTIONS I.V. SOLUTIONS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2022-04-14 2022-04-14
Actual start date 2022-04-14 2022-04-14
Estimated end date 2022-04-22 2022-04-22
Actual end date 2022-04-20 2022-04-20
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments